Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4342-4346

  Bertolini, Francesco ^a   Paul, Saki ^a   Mancuso, Patrizia ^a   Monestiroli, Silvia ^a   Gobbi, Alberto ^a   Shaked, Yuval ^b   Kerbel, Robert S ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL MOTILITY; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; IMMUNE DEFICIENCY; LYMPHOMA; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BURKITT LYMPHOMA; CELL MOVEMENT; CELL SURVIVAL; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; LYMPHOMA, MANTLE-CELL; MICE; MICE, INBRED NOD; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS;

EID: 0041589524     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science (Wash. DC), 275: 964-967, 1997.
2. Shi, Q., Rafii, S., Wu, M. H., Wijelath, E. S., Yu, C., Ishida, A., Fujita, Y., Kothari, S., Mohle, R., Sauvage, L. R., Moore, M. A., Storb, R. F., and Hammond, W. P. Evidence for circulating bone marrow-derived endothelial cells. Blood, 92: 362-367, 1998.
3. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., Wu, Y., Hicklin, D., Zhu, Z., Hackett, N. R., Crystal, R. G., Moore, M. A., Hajjar, K. A., Manova, K., Benezra, R., and Rafii, S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med., 7: 1194-1201, 2001.
4. de Bont, E. S., Guikema, J. E., Scherpen, F., Meeuwsen, T., Kamps, W. A., Vellenga, E., and Bos, N. A. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma. Cancer Res., 61: 7654-7659, 2001.
5. Bolontrade, M. F., Zhou, R. R., and Kleinerman, E. S. Vasculogenesis Plays a Role in the Growth of Ewing's Sarcoma in vivo. Clin. Cancer Res., 8: 3622-3627, 2002.
6. Shirakawa, K., Furuhata, S., Watanabe, I., Hayase, H., Shimizu, A., Ikarashi, Y., Yoshida, T., Terada, M., Hashimoto, D., and Wakasugi, H. Induction of vasculogenesis in breast cancer models. Br. J. Cancer, 87: 1454-1461, 2002.
7. Monestiroli, S., Mancuso, P., Burlini, A., Pruneri, G., Dell'Agnola, C., Gobbi, A., Martinelli, G., and Bertolini, F. Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma. Cancer Res., 61: 4341-4344, 2001.
8. Capillo, M., Mancuso, P., Gobbi, A., Monestiroli, S., Pruneri, G., Dell'Agnola, C., Martinelli, G., Shultz, L., and Bertolini, F. Continuous infusion of endostatin inhibits differentiation, mobilization and clonogenic potential of endothelial cell progenitors. Clin. Cancer Res., 9: 377-382, 2003.
9. Mancuso, P., Burlini, A., Pruneri, G., Goldhirsch, A., Martinelli, G., and Bertolini, F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood, 97: 3658-3661, 2001.
10. Lapidot, T., and Petit, I. Current understanding of stem cell mobilization: the roles of chemokine. Exp. Hematol., 30: 973-981, 2002.
11. Browder, T., Butterfield, C. E., Kraling, B. M., Shi, B., Marshall, B., O'Reilly, M. S., and Folkman, J. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res., 60: 1878-1886, 2000.
12. Man, S., Bocci, G., Francia, G., Green, S. K., Jothy, S., Hanahan, D., Bohlen, P., Hicklin, D. J., Bergers, G., and Kerbel, R. S. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res., 62: 2731-2735, 2002.
13. Kerbel, R., and Folkman, J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer, 2: 727-739, 2002.
14. Bertolini, F., Fusetti, L., Mancuso, P., Gobbi, A., Corsini, C., Ferrucci, P. F., Martinelli, G., and Pruneri, G. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin's lymphoma. Blood, 96: 282-287, 2000.
15. Philpott, N. J., Turner, A. J., Scopes, J., Westby, M., Marsh, J. C., Gordon-Smith, E. C., Dalgleish, A. G., and Gibson, F. M. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood, 87: 2244-2251, 1996.
16. Bhagwat, S. V., Lahdenranta, J., Giordano, R., Arap, W., Pasqualini, R., and Shapiro, L. H. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood, 97: 652-659, 2001.
17. Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A., Werb, Z., and Rafii, S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell, 109: 625-637, 2002.
18. Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., and Isner, J. M. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J., 18: 3964-3972, 1999.
19. Papayannopoulou, T., Priestley, G. V., Nakamoto, B., Zafiropoulos, V., and Scott, L. M. Molecular pathways in bone marrow homing: dominant role of α4β1 over β2-integrins and selectins. Blood, 98: 2403-2411, 2001.
20. Yamaguchi, J., Kusano, K. F., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S., Bosch-Marce, M., Masuda, H., Losordo, D. W., Isner, J. M., and Asahara, T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation, 107: 1322-1328, 2003.
21. Colleoni, M., Rocca, A., Sandri, M. T., Zorzino, L., Masci, G., Nolè, F., Peruzzotti, G., Robertson, C., Orlando, L., Cinieri, S., de Braud, F., Viale, G., and Goldhirsch, A. Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann. Oncol., 13: 73-80, 2002.